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sensitivity of these tumour cells to hormonal
stimulation. This treatment results in the
decrease in plasma testosterone, and al-
though the effectiveness ofthe therapy might
suggest that this androgen or its prostatic
metabolites may have some aetiological role
in the development of cancer of the prostate,
thereisatpresentlittleevidence toincriminate
any hormonal imbalance. It is of interest,
however, that McNeal (1970, Proc. 3rd
Tenovus Workshop, p. 23) has recently
challenged thetraditionalview that carcinoma
of the prostate orginates from atrophic,
androgen deprived epithelium of the gland
in the elderly man. Instead, he suggests that
carcinoma arises from active glandular
epithelium, again directing attention to an
aetiological role of prolonged androgenic
stimulation.
It is obvious therefore that further studies
are required of the relationship between pro-
static disease and endocrine function. Investi-
gations from these laboratories have to date
failedtoshowany majorsignificantdifferences
inthelevelsofprolactin, LH,FSH,androstene-
dione, testosterone oroestradiol-17/3 inplasma
fromnormalmen and those with either benign
prostatic hyperplasia or carcinoma of the
gland. More detailed studies in which plasma
hormone levels in patients on oestrogen
therapy were carefully monitored indicated
differences in the endocrine response between
patients and suggested that such studies may
provide more relevant and interesting data.
For example, the prolactin levels in the
plasma were found to be markedly elevated in
certain patients after initiation of oestrogen
therapy. Many earlier studies have directed
attention to the possible relationship between
prolactin and the prostate, and it is also
known that hypophysectomy can still pro-
duce regression of prostatic carcinoma even
after orchidectomy and adrenalectomy
(Fergusson, 1972, in Endocrine Therapy in
Malignant Disease, p. 237).
The eventual lack of responsiveness to
oestrogen therapy in many patients, resulting
in progression of the disease, has been
considered due to secondary production of
androgen by the adrenal. A series of
Synacthen stimulation tests on patients
before and during diethylstilboestrol therapy
indicated an increased capacity of the
adrenal to produce testosterone during
treatment.
Little information exists on human
prostatic steroid receptor complexes. Such
steroid receptor studies in relation to hormone
action within the prostatic cell are particu-
larly valuable, and may eventually indicate
the mechanism by which oestrogens can
directly influence the metabolism of the
prostate.
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The assay of steroid hormone receptors is
now widely used as an index of hormone
dependency of certain cancers, since it is
known that receptors are required for the
full course of hormonal action. A variety of
procedures have been employedfor evaluating
the spare (unused) receptor content of
tissues. They make use of the high affinities
of receptors for their respective steroids,
which allows the measurement of labelled
steroid receptor complexes, after separation
from excess of free steroid and dissociation of
unspecific complexes. Another requirement
for accurate receptor assay is the ability to
distinguish between steroid receptor com-
plexes and those formed with specific plasma
proteins, contaminating tissue extracts.
All requirements are met in a single step by
the very sensitive agar gel electrophoresis at
low temperature, which allows e.g. the
determination of oestrogen- and androgen
receptors in mammary and prostate cancer
in the presence of sex hormone binding
protein (Wagner, 1972). In assessing the
predictive value of quantitative receptor
assays in cancers, it has to be considered that
the concentration of spare receptor depends
not only on the uniformity of the tissue
specimen investigated but also on the
hormonal status of the patient. Hormone
action is always accompanied by receptor
depletion and replenishment. The latter is
due to de novo synthesis rather than to
recycling of used receptor. Continuous
hormone supply can thus result in low actual
concentrations of spare receptor, which
should not be mistaken as an indicator of
" marginal " hormone dependency.